Z

Zai Lab (US) LLC

Develops, licenses, markets biopharmaceutical therapies

Associate Director, Clinical Pharmacology & MIDD - Clinical Pharmacology & MIDD

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeSouth San Francisco, CA, USA

About the Job

Requirements

  • A bachelor's degree in Clinical Pharmacology, Pharmacokinetics, Pharmacometrics, Pharmaceutical Sciences, Systems Pharmacology, Biomedical Engineering, or a related discipline, with 10 years of experience in clinical pharmacology, pharmacometrics, model-informed drug development, or related quantitative sciences supporting drug development; or an equivalent combination of higher education, training, and experience.
  • Demonstrated experience developing and executing integrated Clinical Pharmacology and model-informed drug development strategies across multiple stages of drug development, including regulatory submissions and health authority interactions.
  • Demonstrated ability to use clinical pharmacology and model-informed drug development approaches to influence key development decisions, including dose selection, study design, phase transition, registration strategy, and health authority interactions.
  • Demonstrated expertise in the fit-for-purpose application and critical evaluation of population pharmacokinetics, exposure-response, pharmacokinetics/pharmacodynamics, physiologically based pharmacokinetic modeling, translational modeling, and other quantitative approaches.
  • Proficiency in English is required.
  • Experience leading or overseeing modeling activities conducted internally and through external partners, with the ability to critically assess model assumptions, uncertainty, and regulatory acceptability.
  • Experience mentoring junior scientists and contributing to scientific capability development.
  • Experience in cross-regional collaboration, including Asia/China.
  • Oncology drug development experience.
  • Experience with biologics, antibody-drug conjugates, bispecific antibodies, T-cell engagers, cytokines, radiopharmaceuticals, or other complex therapeutic modalities.
  • Experience applying model-informed drug development approaches to first-in-human dose selection, recommended phase 2 dose determination, dose optimization, and registration strategies.
  • Hands-on experience reviewing or directing quantitative analyses conducted using NONMEM, Monolix, Simcyp, GastroPlus, R, or equivalent platforms.

Responsibilities

  • Serve as the Clinical Pharmacology Lead for assigned programs and provide clinical pharmacology and model-informed drug development strategy from early development through registration and lifecycle management for small and large molecules.
  • Integrate clinical pharmacology principles and model-informed drug development approaches to de-risk and accelerate programs and inform critical go/no-go decisions, first-in-human planning, dose escalation, dose optimization, recommended phase 2 dose selection, study design, and development strategy.
  • Develop and execute integrated Clinical Pharmacology and Modeling & Simulation plans for assigned programs, with clear quantitative objectives linked to key development decisions.
  • Lead the design, execution, analysis, and interpretation of clinical pharmacology studies, including drug-drug interaction, organ impairment, food effect, QTc, bioavailability/bioequivalence, and special population assessments, and translational pharmacokinetics/pharmacodynamics modeling efforts as appropriate.
  • Lead the fit-for-purpose application of quantitative methodologies, including population pharmacokinetics, pharmacokinetics/pharmacodynamics, exposure-response, physiologically based pharmacokinetic modeling, translational modeling, model-based meta-analysis, and quantitative systems pharmacology, to address key drug development questions.
  • Ensure the scientific rigor, quality, and regulatory compliance of clinical pharmacology and model-informed drug development analyses and deliverables, including critical evaluation of model assumptions, uncertainty, qualification, and interpretation.
  • Represent Clinical Pharmacology and model-informed drug development for assigned programs in cross-functional teams and interactions with global health authorities, including the FDA and EMA, in partnership with the Head of Clinical Pharmacology.
  • Lead authorship and critical review of clinical pharmacology and quantitative sections for key documents, including INDs, CTAs, IB updates, briefing packages, health authority responses, and NDAs/BLAs.
  • Present and defend clinical pharmacology and model-informed drug development strategies, modeling approaches, assumptions, and recommendations during internal governance reviews, health authority consultations, and submissions.
  • Provide scientific mentorship and technical guidance to clinical pharmacologists and modelers and contribute to capability building within the function.
  • Translate complex clinical pharmacology concepts and model-based insights into clear, actionable recommendations that influence senior leadership, project teams, and external partners.
  • Provide Clinical Pharmacology and model-informed drug development input to internal governance bodies, including Development Review Committees, portfolio reviews, due diligence, business development activities, and external collaborations.

Desired Qualifications

  • A PhD with at least 7 years of related experience.
  • Ability to work effectively in a highly collaborative, multidisciplinary, and dynamic team setting.
  • Excellent verbal and written communication skills.
  • Being self-directed and highly motivated, with strong problem-solving skills and willingness to learn new tools and approaches.
  • Maintaining the highest standards of integrity and ethics.

About the Company

Zai Lab (US) LLC

Develops, licenses, markets biopharmaceutical therapies

Zai Lab focuses on developing and commercializing therapies for cancer, infectious diseases, and autoimmune disorders, with a primary emphasis on China and the Asia-Pacific region. The company advances its products through R&D, clinical trials, and commercialization, and it manufactures small molecules and biologics in Suzhou to international quality standards. It distinguishes itself by collaborating with global partners to license and develop treatments, leveraging an integrated model that spans discovery, development, and market access in its target regions. Its goal is to bring effective, modern therapies to patients with unmet medical needs in its core markets, supported by product sales, licensing agreements, and strategic partnerships.

Company size
501-1,000
Company stage
IPO
Headquarters
Pudong, China
Founded
2014

Recently Posted Jobs

Explore more opportunities at Zai Lab (US) LLC

See more jobs